Catalyst Wire Dossier Catalyst Wire Dossier

Crisaborole 2% Cream (Eucrisa)

crisaborole · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Crisaborole 2% Cream (Eucrisa), covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema [Phase 4]

See pricing